基于"脾肾双补"理论的金精丸通过6-甲基腺嘌呤甲基化修饰治疗脾肾两虚型少弱精症机制研究OA
Mechanism of Jinjing Pills in treating oligoasthenozoospermia due to spleen-kidney deficiency based on the"dual tonification of the spleen and kidney"theory via N6-methyladenosine methylation modification
目的 基于中医"脾肾双补"理论,探讨金精丸通过调控 6-甲基腺嘌呤(m6A)甲基化修饰治疗脾肾两虚型少弱精子症的作用机制.方法 选择 2020 年 5 月至 2023 年 6 月昆山市中医医院泌尿外科收治的 105 例脾肾两虚型少弱精子症患者为研究对象,采用倾向性评分匹配(PSM)法按 1∶1匹配后分为治疗组与对照组(各 45 例).对照组予左卡尼汀口服溶液及生活方式干预,治疗组在对照组基础上加用金精丸,2 组均治疗 3 个月.比较 2 组精液参数(精液量、精子密度等)、精子 RNA 中 m6A 修饰水平及临床疗效;精液参数与 m6A 修饰水平的关联性采用多元线性回归模型;组间精液参数动态变化采用广义估计方程(GEE)模型.结果 治疗 1、3 个月,2 组精液量、精子密度、向前运动精子(PR)率、精子存活率、直线运动速率、正常形态精子率均显著高于治疗前(P<0.05),且治疗组均高于对照组同期(P<0.05).治疗 1、3 个月,2 组 m6A 水平均较本组治疗前明显降低(P<0.05),且治疗组低于对照组同期(P<0.05).重复测量方差分析结果显示,2 组患者 m6A 的时间主效应、组别主效应和交互效应均存在显著差异(P<0.05).多元线性回归分析显示,m6A 水平与精液量(β=-0.274)、精子密度(β=-0.434)、PR 率(β=-0.356)、精子存活率(β=-0.432)、直线运动速率(β=-0.576)、正常形态精子率(β=-0.272)呈负相关(P<0.05).GEE 模型分析显示,治疗组精子质量改善具有时间累积优势(P<0.001).治疗组和对照组总有效率分别为 88.89%(40/45)、68.89%(31/45),治疗组总有效率高于对照组(P<0.05).结论 金精丸可显著改善脾肾两虚型少弱精子症患者精子质量,其机制可能与抑制精子 RNA 中 m6A 异常甲基化修饰有关.
Objective Based on the traditional Chinese medicine theory of"dual tonification of the spleen and kidney",to investigate the mechanism by which Jinjing Pills improves oligoasthenozoospermia due to spleen-kidney deficiency by regulating N6-methyladenosine(m6A)methylation modification.Methods A total of 105 patients with oligoasthenozoospermia due to spleen-kidney deficiency who were treated in the Department of Urology of Kunshan Hospital of Traditional Chinese Medicine from May 2020 to June 2023 were selected.After propensity score matching(PSM)at a 1∶1 ratio,they were assigned to a treatment group and a control group,with 45 patients in each group.The control group received levocarnitine oral solution and lifestyle intervention,while the treatment group received Jinjing Pills in addition to the treatment given to the control group.Both groups were treated for 3 months.Semen parameters(semen volume,sperm concentration,etc.),m6A modification levels in sperm RNA,and clinical efficacy were compared between the two groups.The association between semen parameters and m6A modification levels was analyzed using a multiple linear regression model.Dynamic changes in semen parameters between groups were analyzed using a generalized estimating equation(GEE)model.Results At 1 and 3 months of treatment,semen volume,sperm concentration,progressive motility(PR)rate,sperm viability,straight-line velocity,and normal morphology rate were all significantly higher in both groups than before treatment(P<0.05),and were higher in the treatment group than in the control group at the corresponding time points(P<0.05).At 1 and 3 months of treatment,m6A levels in both groups were significantly lower than before treatment(P<0.05),and were lower in the treatment group than in the control group at the corresponding time points(P<0.05).Repeated-measures analysis of variance showed significant time effects,group effects,and interaction effects for m6A levels in both groups(P<0.05).Multiple linear regression showed that m6A levels were negatively correlated with semen volume(β=-0.274),sperm concentration(β=-0.434),PR rate(β=-0.356),sperm viability(β=-0.432),straight-line velocity(β=-0.576),and normal morphology rate(β=-0.272)(P<0.05).GEE analysis showed a time-dependent cumulative advantage in sperm quality improvement in the treatment group(P<0.001).The total effective rates were 88.89%(40/45)in the treatment group and 68.89%(31/45)in the control group,with a significantly higher total effective rate in the treatment group(P<0.05).Conclusion Jinjing Pills can significantly improve sperm quality in patients with oligoasthenozoospermia due to spleen-kidney deficiency,and its mechanism may be associated with inhibition of abnormal N6-methyladenosine methylation modification in sperm RNA.
吴余凡;姚林亚;张曦;盛一帆;马俊;王骏;余琪伟
昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300昆山市中医医院泌尿外科,江苏 昆山 215300
医药卫生
少精子症弱精子症脾肾两虚金精丸N6-甲基腺嘌呤机制
OligospermiaAsthenospermiaSpleen-kidney deficiencyJinjing PillN6-methyladenosineMechanism
《河北中医》 2026 (6)
962-969,8
昆山市中医药科技发展基金项目(编号:KZYY2205)昆山市重点研发计划(社会发展)项目(编号:KSZ2203)
评论